IQV240816C220000
- 22.80
- -1.80-7.32%
IQVIA Holdings Newsroom
Morgan Stanley Maintains Overweight on IQVIA Hldgs, Raises Price Target to $280
These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings
Here's Why IQVIA Holdings (IQV) Is a Strong Value Stock
HSBC Adjusts Price Target on IQVIA to $290 From $280
BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $275
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $251 to $300
IQVIA Holdings Price Target Raised to $251.00/Share From $235.00 by Baird
IQVIA Holdings Is Maintained at Neutral by Baird
Express News | Baird Maintains Neutral on IQVIA Hldgs, Raises Price Target to $251
IQVIA Hldgs Analyst Ratings
Evercore ISI Adjusts Price Target on IQVIA Holdings to $270 From $230, Maintains Outperform Rating
Express News | IQVIA Holdings Inc : Morgan Stanley Raises Target Price to $280 From $270
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)
IQVIA Holdings: Strong Q2 Performance and Raised Annual Guidance Prompt 'Buy' Rating
Barclays Sticks to Its Buy Rating for IQVIA Holdings (IQV)
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight
Express News | IQVIA Holdings Inc : Baird Raises Target Price to $251 From $235
IQVIA Holdings: Strong H2 Outlook With Buoyant TAS, RWE, and RDS Segments Driving Buy Rating
Top Gap Ups and Downs on Monday: VZ, T, COP and More
Trending Stocks Today | Volato Group Shoots up 107.7% Post-Market